Apathy is not associated with reduced ventral striatal volume in patients with schizophrenia.


Journal

Schizophrenia research
ISSN: 1573-2509
Titre abrégé: Schizophr Res
Pays: Netherlands
ID NLM: 8804207

Informations de publication

Date de publication:
09 2020
Historique:
received: 05 01 2020
revised: 04 05 2020
accepted: 24 08 2020
pubmed: 16 9 2020
medline: 22 6 2021
entrez: 15 9 2020
Statut: ppublish

Résumé

A growing body of neuroimaging research has revealed a relationship between blunted activation of the ventral striatum (VS) and apathy in schizophrenia. In contrast, the association between reduced striatal volume and apathy is less well established, while the relationship between VS function and structure in patients with schizophrenia remains an open question. Here, we aimed to replicate previous structural findings in a larger independent sample and to investigate the relationship between VS hypoactivation and VS volume. We included brain structural magnetic resonance imaging (MRI) data from 60 patients with schizophrenia (SZ) that had shown an association of VS hypoactivation with apathy during reward anticipation and 58 healthy controls (HC). To improve replicability, we applied analytical methods employed in two previously published studies: Voxel-based morphometry and the Multiple Automatically Generated Templates (MAGeT) algorithm. VS and dorsal striatum (DS) volume were correlated with apathy correcting for age, gender and total brain volume. Additionally, left VS activity was correlated with left VS volume. We failed to replicate the association between apathy and reduced VS volume and did not find a correlation with DS volume. Functional and structural left VS measures exhibited a trend-level correlation (r Our present data suggests that functional and structural striatal neuroimaging correlates of apathy can occur independently. Replication of previous findings may have been limited by other factors (medication, illness duration, age) potentially related to striatal volume changes in SZ. Finally, associations between reward-related VS function and structure should be further explored.

Sections du résumé

BACKGROUND
A growing body of neuroimaging research has revealed a relationship between blunted activation of the ventral striatum (VS) and apathy in schizophrenia. In contrast, the association between reduced striatal volume and apathy is less well established, while the relationship between VS function and structure in patients with schizophrenia remains an open question. Here, we aimed to replicate previous structural findings in a larger independent sample and to investigate the relationship between VS hypoactivation and VS volume.
METHODS
We included brain structural magnetic resonance imaging (MRI) data from 60 patients with schizophrenia (SZ) that had shown an association of VS hypoactivation with apathy during reward anticipation and 58 healthy controls (HC). To improve replicability, we applied analytical methods employed in two previously published studies: Voxel-based morphometry and the Multiple Automatically Generated Templates (MAGeT) algorithm. VS and dorsal striatum (DS) volume were correlated with apathy correcting for age, gender and total brain volume. Additionally, left VS activity was correlated with left VS volume.
RESULTS
We failed to replicate the association between apathy and reduced VS volume and did not find a correlation with DS volume. Functional and structural left VS measures exhibited a trend-level correlation (r
CONCLUSIONS
Our present data suggests that functional and structural striatal neuroimaging correlates of apathy can occur independently. Replication of previous findings may have been limited by other factors (medication, illness duration, age) potentially related to striatal volume changes in SZ. Finally, associations between reward-related VS function and structure should be further explored.

Identifiants

pubmed: 32928618
pii: S0920-9964(20)30446-1
doi: 10.1016/j.schres.2020.08.018
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

279-288

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest SK has received royalties for cognitive test and training software from Schuhfried. The other authors declare that they have no conflicts of interest.

Auteurs

Achim Burrer (A)

Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, Switzerland.

Fernando Caravaggio (F)

Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

Andrei Manoliu (A)

Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, Switzerland; Wellcome Centre for Human Neuroimaging, University College London, London, United Kingdom; Max Planck University College London, Centre for Computational Psychiatry and Ageing Research, London, United Kingdom.

Eric Plitman (E)

Cerebral Imaging Centre, Douglas Mental Health University Institute, Montreal, QC, Canada.

Karoline Gütter (K)

Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, Switzerland.

Benedikt Habermeyer (B)

Psychiatric Services Aargau, Brugg, Switzerland.

Philipp Stämpfli (P)

Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, Switzerland.

Aslan Abivardi (A)

Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, Switzerland.

André Schmidt (A)

Department of Psychiatry, Psychiatric Hospital, University of Basel, Basel, Switzerland.

Stefan Borgwardt (S)

Department of Psychiatry, Psychiatric Hospital, University of Basel, Basel, Switzerland.

Mallar Chakravarty (M)

Cerebral Imaging Centre, Douglas Mental Health University Institute, Montreal, QC, Canada.

Martin Lepage (M)

Cerebral Imaging Centre, Douglas Mental Health University Institute, Montreal, QC, Canada.

Alain Dagher (A)

McConnell Brain Imaging Centre, Montreal Neurological Institute and Hospital, Montreal, Canada.

Ariel Graff-Guerrero (A)

Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

Erich Seifritz (E)

Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, Switzerland.

Stefan Kaiser (S)

Division of Adult Psychiatry, Department of Mental Health and Psychiatry, Geneva University Hospitals, Geneva, Switzerland.

Matthias Kirschner (M)

Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, Switzerland; McConnell Brain Imaging Centre, Montreal Neurological Institute and Hospital, Montreal, Canada. Electronic address: matthias.kirschner@mail.mcgill.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH